📢Our 2025 Annual Report is here! 📢
In 2025, we awarded $43.4M in grant funding to leading researchers around the world. Learn more about how our grantees are advancing cancer diagnosis and treatment:
https://t.co/OCBcfx4lXm
Chordoma researchers: @BenjaminGVincen has shared predicted brachyury (TBXT) epitopes, which could help inform immunotherapy development: https://t.co/ynT0HdD0fI
If you're interested in advancing research like this, we encourage you to explore ASPIRE, our new funding opportunity with @TheMarkFdn for chordoma surface-target research: https://t.co/967Em6sGoF
Have you heard yesterday's episode of The Daily by @nytimes? It traces how a century-old idea for a cancer vaccine became a real treatment. Stories like this are why we back bold, cross-disciplinary teams turning tomorrow’s long shots into patient care. 🎧👇
https://t.co/vYPmL7NQwL
We're hiring! OSI is seeking a Director of Scientific Programs to help advance osteosarcoma research and bring new treatments to patients faster. This is the first of two new roles as our team grows!
Apply by Dec. 15: https://t.co/TpWFqKPzmU
Planning to apply for the TBXT and Beyond ASPIRE Awards? Join The Mark Foundation and @ChordomaFDN for an informational webinar this Thursday, Nov. 12 at 11 a.m. EST.
Link to register: https://t.co/4IH5Nx1UUq
In a letter to the @nytimes, our CEO Ryan Schoenfeld weighs in on recent federal grant cuts—and why the leaders of the AI boom are uniquely suited to back high-risk frontier oncology: https://t.co/XkQMvipsxn
Planning to apply for the TBXT and Beyond ASPIRE Awards? Join The Mark Foundation and @ChordomaFDN for an informational webinar this Thursday, Nov. 12 at 11 a.m. EST.
Link to register: https://t.co/4IH5Nx1UUq
Thinking about applying for a TBXT and Beyond ASPIRE Award?
With our partners at the @ChordomaFDN, we are hosting an informal informational webinar on Nov. 12 to share more details about this grant opportunity focused on expanding the chordoma surfaceome. Register now: https://t.co/4rKl2g6YQP
Early detection matters! 💗
I'm sharing my personal breast cancer story and how a routine screening mammogram led to an early diagnosis that made all the difference.
Watch my story and learn why early detection is so important. Get screened—it could save your life! 🎀
Breast cancer doctor faces her own diagnosis https://t.co/BuyachyFPL via @GMA
Congrats to Janis Taube & Alexander Szalay of @themarkfdn Center for Advanced Genomics and Imaging at @HopkinsKimmel! Their AstroPath platform, which uses celestial mapping tools for cancer imaging, has been chosen for @AnthropicAI's AI for Science program.
https://t.co/Gz0PeClx8W
@HopkinsKimmel researchers' pioneering AstroPath technology, which combines astronomy, pathology and AI to map tumors and reveal how cancer cells interact with the immune system, has been selected for Anthropic's AI for Science program. @TheMarkFdn
https://t.co/mCRv0KnY0g
Transformative cancer discoveries happen at the intersection of disciplines.
Join us in celebrating these innovative investigators as they push the frontiers of chemistry to deliver novel therapeutic strategies for patients.
Read more: https://t.co/6oN4E0q9TI
We are proud to partner with the @AACR to announce the recipients of the 2026 AACR-Mark Foundation Chemistry in Cancer Research Grants!
These awards support pioneering chemists leveraging chemical biology to address some of the most urgent challenges in oncology. 🧵👇
https://t.co/LgfHVtJYCf
The #ESMO26 Award for Translational Research recognises @landau_lab pioneering contributions to advancing our understanding of #cancer evolution through innovative genomic and computational #research.
Find out more:https://t.co/FEtRIgwkc5
#InsightsbyESMO
🚨Now accepting grant proposals!🚨
In partnership with @chordomafdn, we are launching the TBXT and Beyond ASPIRE Awards to accelerate novel therapeutic strategies targeting the chordoma surfaceome.
💵 Up to $500K over 24 months
🗓️ LOIs due: Dec 10
https://t.co/0qINfu31ze
🧵👇
🔬 Open to independent investigators at non-profit research institutions worldwide. Co-investigators welcome.
Awardees will also be encouraged to leverage @chordomafdn’s suite of research-enabling tools and disease models to accelerate discovery.